Reporting Zika Pregnancy & Infant Outcomes in California
The U.S. Centers for Disease Control and Prevention (CDC) has established a national US Zika Pregnancy Registry to address questions about Zika-associated birth defects and other pregnancy outcomes. All data reported to the U.S. Zika Pregnancy Registry will be de-identified and healthcare provider participation is voluntary. The California Department of Public Health (CDPH) is participating in the U.S. Zika Pregnancy Registry and is the point of contact for California data submission to CDC. CDPH is working with local health departments and healthcare providers to complete the U.S. Zika Pregnancy Registry data collection forms for submission to CDC.
Data ColUSZPR-ZBDS-Data-Abstraction-Guidelection Points
The U.S. Zika Pregnancy Registry potential data collection points include the time of maternal diagnosis, second trimester, third trimester, delivery, and infant follow-up at 2, 6 and 12 months.
Eligibility for Inclusion in the Registry
- Pregnant women in the United States with laboratory evidence of Zika virus infection (positive or equivocal test results, regardless of whether they have symptoms) and periconceptionally, prenatally or perinatally exposed infants born to these women.
- Infants with laboratory evidence of congenital Zika virus infection (positive or equivocal test results, regardless of whether they have symptoms) and their mothers.
U.S. Zika Pregnancy Registry - How to Participate
For more information on the U.S. Zika Pregnancy Registry and how to report outcomes, contact CDPH at:
Phone: (510) 620-3151
Fax: (510) 620-3152